trial · primary record
E7130
Solid Tumors
| Phase | Phase 1 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 62 |
| Primary completion | 2024-12-27 |
| Primary endpoint | Part 1: Number of Participants Assigned to Every 2 Weeks Regimen With Dose-limiting Toxicities (DLTs) |
| Registry ID | NCT03444701 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:19.369Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03444701
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.